Nurix Therapeutics (NRIX) Net Income towards Common Stockholders (QoQ) (2019 - 2026)
Nurix Therapeutics (NRIX) Net Income towards Common Stockholders (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -1.80% |
| Feb 28, 2026 | -12.44% |
| Nov 30, 2025 | 9.49% |
| Aug 31, 2025 | -98.83% |
| May 31, 2025 | 22.87% |
| Feb 28, 2025 | 3.75% |
| Nov 30, 2024 | -19.60% |
| Aug 31, 2024 | -9.90% |
| May 31, 2024 | -7.29% |
| Feb 29, 2024 | 1.04% |
| Nov 30, 2023 | -13.45% |
| Aug 31, 2023 | -52.33% |
| May 31, 2023 | 40.40% |
| Feb 28, 2023 | 12.81% |
| Nov 30, 2022 | -2.21% |
| Aug 31, 2022 | -0.68% |
| May 31, 2022 | -6.74% |
| Feb 28, 2022 | -12.85% |
| Nov 30, 2021 | -30.60% |
| Aug 31, 2021 | -9.55% |